NCT06933420 - Clinical Protocol CERN Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 6, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Bacterial VaginosisFungal Vaginal Infections

Interventions

DEVICE

Cern Device

The Cern Device is an Intravaginal device utilizing low level microbicidal visible light at a 450nm low level microbicidal light, in visible spectrum for treatment of vaginitis, including both bacterial vaginosis and fungal vaginitis.

Trial Locations (3)

92618

RECRUITING

Akerman Med, Irvine

92707

RECRUITING

Akerman Med, Santa Ana

92868

RECRUITING

Akerman Med, Orange